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The processing of amyloid precursor protein (APP) to Ab
is an important event in the pathogenesis of Alzheimer’s
disease (AD). Previous studies suggest that dysregulation
of Wnt signaling is involved in the etiology of AD. Genetic
variation in the Wnt receptor, low-density lipoprotein
receptor-related 6 (LRP6), which is associated with
reduced Wnt signaling has been reported as a risk factor
for AD. In the present study, we found that LRP6 expres-
sion is down-regulated in AD brains. LRP6 and APP colo-
calized in neurons and interact with one another through
their extracellular domains. LRP6 overexpression increases
cell surface levels of APP and decreases Ab production,
while RNA interference of LRP6 expression increases APP
endocytosis and Ab levels. These results demonstrate that
LRP6 plays an important role in the regulation of APP
trafficking and processing to Ab. Our findings suggest that
rescuing LRP6-mediated Wnt signaling might be an
attractive therapeutic strategy for AD.
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